Figure 1 | Modern Pathology

Figure 1

From: Caspase-3 activation in systemic anaplastic large-cell lymphoma

Figure 1

Evaluation of cell viability using trypan blue staining: (a) The mean percentage of viable SU-DHL-1 cells after treatment with 5 μM of doxorubicin decreased from 96 to 38% at 20 h. DEVD-FMK rescued most SU-DHL-1 cells (viable cells 74%), whereas Boc-D-FMK rescued almost all SU-DHL-1 cells (viable cells, 91%). (b) Similarly, treatment of Karpas 299 cells with 5 μM of doxorubicin resulted in 47% cell viability, whereas addition of DEVD-FMK and Boc-D-FMK resulted in 64 and 77% viable cells, respectively.

Back to article page